Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Telmisartan/Amlodipine
Dong Wang
Hypertension With Hyperlipidemia
1 trial -
evogliptin
Dong Wang
Type 2 Diabetes Mellitus
1 trial -
DA-4001C
Dong Wang
Androgenetic Alopecia
1 trial -
Aricept 5mg Tablet
Dong Wang
Healthy
1 trial -
DA-5210 10/500mg
Dong Wang
Healthy
1 trial -
De-escalation strategy
Dong Wang
Acute Myocardial Infarction
1 trial -
Risedronate Sodium 35 MG [Actonel]
Dong Wang
Postmenopausal Osteoporosis
1 trial -
rivastigmine patch
Dong Wang
Alzheimer's Disease
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources